mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |